In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed at $8.42 in the last session, up 0.72% from day before closing price of $8.36. In other words, the price has increased by $0.72 from its previous closing price. On the day, 0.63 million shares were traded. MRVI stock price reached its highest trading level at $8.505 during the session, while it also had its lowest trading level at $8.24.
Ratios:
We take a closer look at MRVI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.28 and its Current Ratio is at 10.00. In the meantime, Its Debt-to-Equity ratio is 1.29 whereas as Long-Term Debt/Eq ratio is at 1.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Overweight rating and assigned the stock a target price of $10.
On August 13, 2024, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $11 to $10.
On April 10, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $15.Craig Hallum initiated its Buy rating on April 10, 2024, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 28 ’24 when GTCR INVESTMENT XI LLC sold 9,940,974 shares for $9.81 per share. The transaction valued at 97,570,660 led to the insider holds 20,150,005 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 2123835520 and an Enterprise Value of 1566819072. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.28 while its Price-to-Book (P/B) ratio in mrq is 2.73. Its current Enterprise Value per Revenue stands at 5.624 whereas that against EBITDA is 758.016.
Stock Price History:
Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.52. The 50-Day Moving Average of the stock is -4.60%, while the 200-Day Moving Average is calculated to be 6.50%.
Shares Statistics:
According to the various share statistics, MRVI traded on average about 2.36M shares per day over the past 3-months and 1574420 shares per day over the past 10 days. A total of 132.23M shares are outstanding, with a floating share count of 117.52M. Insiders hold about 16.98% of the company’s shares, while institutions hold 90.01% stake in the company. Shares short for MRVI as of 1726185600 were 7913465 with a Short Ratio of 3.35, compared to 1723680000 on 8441387. Therefore, it implies a Short% of Shares Outstanding of 7913465 and a Short% of Float of 6.670000399999999.
